 |
|
|
| |
Raltegravir (RAL) Resistant Isolates without Primary RAL Integrase (IN)
Mutations are Cross-resistant to Elvitegravir (EVG) but not Dolutegravir (DTG)
|
| |
| |
Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-7 2014, Berlin, Germany
MR Underwood1, J Horton1, F DeAnda1
1 GlaxoSmithKline, North Carolina, USA
|
| |
|
|
|
|
|
